Report overview
This report contains market size and forecasts of Nasopharyngeal Cancer Drug in global, including the following market information:
Global Nasopharyngeal Cancer Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Nasopharyngeal Cancer Drug Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Nasopharyngeal Cancer Drug companies in 2021 (%)
The global Nasopharyngeal Cancer Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
BGBA-317 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nasopharyngeal Cancer Drug include Ambrx Inc, arGEN-X BV, Atara Biotherapeutics Inc, AVEO Pharmaceuticals Inc, BeiGene Ltd, BioDiem Ltd, Biomics Biotechnologies Co Ltd, Bristol-Myers Squibb Company and CBT Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nasopharyngeal Cancer Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasopharyngeal Cancer Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Nasopharyngeal Cancer Drug Market Segment Percentages, by Type, 2021 (%)
BGBA-317
CBT-501
Apatinib
APG-1387
ARGX-110
ATA-129
Others
Global Nasopharyngeal Cancer Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Nasopharyngeal Cancer Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Nasopharyngeal Cancer Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Nasopharyngeal Cancer Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nasopharyngeal Cancer Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Nasopharyngeal Cancer Drug revenues share in global market, 2021 (%)
Key companies Nasopharyngeal Cancer Drug sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Nasopharyngeal Cancer Drug sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ambrx Inc
arGEN-X BV
Atara Biotherapeutics Inc
AVEO Pharmaceuticals Inc
BeiGene Ltd
BioDiem Ltd
Biomics Biotechnologies Co Ltd
Bristol-Myers Squibb Company
CBT Pharmaceuticals Inc
Celgene Corp
Cell Medica Ltd
F. Hoffmann-La Roche Ltd
GlaxoSmithKline Plc
